UK Markets close in 7 hrs 36 mins

Basilea Pharmaceutica AG (0QNA.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
48.60+0.40 (+0.82%)
As of 05:56PM GMT. Market open.
Currency in CHF

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.84
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 30.00
52-week low 30.00
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 510.87M
Implied shares outstanding 6N/A
Float 811.47M
% held by insiders 13.08%
% held by institutions 126.59%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Jun 2022

Profitability

Profit margin 0.56%
Operating margin (ttm)6.35%

Management effectiveness

Return on assets (ttm)2.61%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)152.57M
Revenue per share (ttm)12.91
Quarterly revenue growth (yoy)8.20%
Gross profit (ttm)30.89M
EBITDA 10.2M
Net income avi to common (ttm)851k
Diluted EPS (ttm)-1.43
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)140.74M
Total cash per share (mrq)11.89
Total debt (mrq)231.31M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.36
Book value per share (mrq)-9.39

Cash flow statement

Operating cash flow (ttm)-4.72M
Levered free cash flow (ttm)-7.52M